Toll Free: 1-888-928-9744
Published: Dec, 2014 | Pages:
50 | Publisher: Global Markets Direct
Industry: Healthcare | Report Format: Electronic (PDF)
Ageing - Pipeline Review, H2 2014 Summary Global Markets Direct's, 'Ageing - Pipeline Review, H2 2014', provides an overview of the Ageing's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ageing, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ageing and special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Ageing - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Ageing and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Ageing products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Ageing pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Ageing - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Ageing pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Global Markets Direct Report Coverage 6 Ageing Overview 7 Therapeutics Development 8 Pipeline Products for Ageing - Overview 8 Pipeline Products for Ageing - Comparative Analysis 9 Ageing - Therapeutics under Development by Companies 10 Ageing - Therapeutics under Investigation by Universities/Institutes 11 Ageing - Pipeline Products Glance 12 Early Stage Products 12 Ageing - Products under Development by Companies 13 Ageing - Products under Investigation by Universities/Institutes 14 Ageing - Companies Involved in Therapeutics Development 15 Bioo Therapeutics 15 Neuralstem, Inc. 16 RepliCel Life Sciences, Inc. 17 RXi Pharmaceuticals Corporation 18 vida therapeutics inc. 19 Ageing - Therapeutics Assessment 20 Assessment by Monotherapy Products 20 Assessment by Combination Products 21 Assessment by Target 22 Assessment by Mechanism of Action 24 Assessment by Route of Administration 26 Assessment by Molecule Type 28 Drug Profiles 30 BIOO-4 - Drug Profile 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 BIOO-7 - Drug Profile 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 Drugs for Ageing - Drug Profile 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 metformin + sirolimus - Drug Profile 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 MG-29 - Drug Profile 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 MMP-26051 - Drug Profile 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 MMP-26052 - Drug Profile 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 NSI-189 - Drug Profile 37 Product Description 37 Mechanism of Action 37 R&D Progress 37 RCS-01 - Drug Profile 38 Product Description 38 Mechanism of Action 38 R&D Progress 38 sirolimus - Drug Profile 39 Product Description 39 Mechanism of Action 39 R&D Progress 39 Small Molecule for Alzheimer's Disease and Ageing - Drug Profile 40 Product Description 40 Mechanism of Action 40 R&D Progress 40 TM-5441 - Drug Profile 41 Product Description 41 Mechanism of Action 41 R&D Progress 41 V-2248 - Drug Profile 43 Product Description 43 Mechanism of Action 43 R&D Progress 43 Ageing - Recent Pipeline Updates 44 Ageing - Dormant Projects 47 Ageing - Product Development Milestones 48 Featured News & Press Releases 48 Oct 09, 2014: RepliCel to Present Commercial and Clinical Update on RCS-01 at BioJapan 2014 World Business Forum 48 Appendix 49 Methodology 49 Coverage 49 Secondary Research 49 Primary Research 49 Expert Panel Validation 49 Contact Us 50 Disclaimer 50
List of Tables Number of Products under Development for Ageing, H2 2014 8 Number of Products under Development for Ageing - Comparative Analysis, H2 2014 9 Number of Products under Development by Companies, H2 2014 10 Number of Products under Investigation by Universities/Institutes, H2 2014 11 Comparative Analysis by Early Stage Development, H2 2014 12 Products under Development by Companies, H2 2014 13 Products under Investigation by Universities/Institutes, H2 2014 14 Ageing - Pipeline by Bioo Therapeutics, H2 2014 15 Ageing - Pipeline by Neuralstem, Inc., H2 2014 16 Ageing - Pipeline by RepliCel Life Sciences, Inc., H2 2014 17 Ageing - Pipeline by RXi Pharmaceuticals Corporation, H2 2014 18 Ageing - Pipeline by vida therapeutics inc., H2 2014 19 Assessment by Monotherapy Products, H2 2014 20 Assessment by Combination Products, H2 2014 21 Number of Products by Stage and Target, H2 2014 23 Number of Products by Stage and Mechanism of Action, H2 2014 25 Number of Products by Stage and Route of Administration, H2 2014 27 Number of Products by Stage and Molecule Type, H2 2014 29 Ageing Therapeutics - Recent Pipeline Updates, H2 2014 44 Ageing - Dormant Projects, H2 2014 47
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.